oxybutynin
NDC 0615-8220, oxybutynin, tablet, film coated, extended release, from NCS HealthCare of KY, LLC dba Vangard Labs.
- Product NDC
- 0615-8220
- Status
- Listed
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202332
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE10 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0615-8220-39 | 00615822039 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8220-39) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ec4fd95f-16dc-4acf-b560-b67b7aaef08b
Use it
Look up 0615-8220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0615-8220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.